Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Novartis
Julphar
Queensland Health
Chubb
Chinese Patent Office
Moodys
Mallinckrodt
Federal Trade Commission

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,846,961

« Back to Dashboard

Which drugs does patent 7,846,961 protect, and when does it expire?

Patent 7,846,961 protects PRESTALIA and is included in one NDA.

This patent has twenty-six patent family members in twenty-six countries.
Summary for Patent: 7,846,961
Title:.alpha. crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
Abstract: .alpha.-crystalline form of the compound of formula (I): ##STR00001## characterized by its powder X-ray diffraction diagram. Medicinal products containing the same which are useful as inhibitors of angiotensin I converting enzyme.
Inventor(s): Coquerel; Gerard (Boos, FR), Lefebvre; Loic (Mont Saint Aignan, FR), Souvie; Jean-Claude (Pau, FR), Authouart; Pascale (Les Trois Pierres, FR)
Assignee: Les Laboratoires Servier (Suresnes Cedex, FR)
Application Number:12/224,369
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;

Drugs Protected by US Patent 7,846,961

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Symplmed Pharms Llc PRESTALIA amlodipine besylate; perindopril arginine TABLET;ORAL 205003-001 Jan 21, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y Y TREATMENT OF HYPERTENSION ➤ Subscribe
Symplmed Pharms Llc PRESTALIA amlodipine besylate; perindopril arginine TABLET;ORAL 205003-002 Jan 21, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y Y TREATMENT OF HYPERTENSION ➤ Subscribe
Symplmed Pharms Llc PRESTALIA amlodipine besylate; perindopril arginine TABLET;ORAL 205003-003 Jan 21, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y TREATMENT OF HYPERTENSION ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,846,961

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France06 01748Feb 28, 2006
PCT Information
PCT FiledFebruary 26, 2007PCT Application Number:PCT/FR2007/000335
PCT Publication Date:September 07, 2007PCT Publication Number: WO2007/099217

International Patents Family Members for US Patent 7,846,961

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2007220435 ➤ Subscribe
Brazil PI0708278 ➤ Subscribe
Canada 2644467 ➤ Subscribe
China 101389603 ➤ Subscribe
Cyprus 1117753 ➤ Subscribe
Denmark 1989182 ➤ Subscribe
Eurasian Patent Organization 014716 ➤ Subscribe
Eurasian Patent Organization 200801777 ➤ Subscribe
European Patent Office 1989182 ➤ Subscribe
Spain 2581982 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
AstraZeneca
Merck
US Army
Express Scripts
Federal Trade Commission
Chinese Patent Office
Novartis
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot